Illustration of how spectral CT can help confirm findings on a conventional CT scan without requiring follow-up imaging, such as a nuclear scan. The conventional CT on the left, and the dual-energy CT on the right confirms an infarct.
Feature | Computed Tomography (CT)
Philips Introduces the new Spectral CT 7500 as Workhorse Scanner With Spectral Data on Every Scan

May 27, 2021 — Philips Healthcare released a workhorse computed tomography (CT) system, the Spectral CT 7500, which has ...

Home May 27, 2021
Home
Videos | Congenital Heart
VIDEO: Advances in Congenital Heart Therapy Technologies

Tom Jones, M.D., director, cardiac catheterization laboratories, Seattle Children’s Hospital, explains some of the new ...

Home May 26, 2021
Home
The Acurate neo2 TAVR valve design enhancements include a 60% larger outer sealing skirt to conform to challenging anatomies. This has minimized paravalvular leaks and imporved clinical outcomes compared to the previous-generation Acurate neo Aortic Valve System. #EuroPCR #EuroPCR21 #EuroPCR2021
Feature | Structural Heart
Acurate neo2 TAVR Valve Demonstrate Reduced Paravalvular Leak and Low Permanent Pacemaker Rates 

May 26, 2021 — Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress for the updated ...

Home May 26, 2021
Home
Left, the AcQCross Transseptal Crossing Device offers versatility to be utilized with top sheaths currently used in left atrium EP and structural heart procedures. Right, the AcQMap next-generation mapping catheter integrates high-resolution ultrasound-based imaging and non-contact mapping catheter with improved torque response, handling and maneuverability.
News | EP Lab
Acutus Gains European CE Mark for Suite of Next Generation EP Products

May 25, 2021 — Acutus Medical Inc. announced European CE mark approval for a broad suite of electrophysiology (EP) ...

Home May 25, 2021
Home
iRhythm Technologies Inc. announced two new U.S. Food and Drug Administration (FDA) 510(k) clearances — one for a new and improved design of its flagship Zio wearable cardiac monitor, and a second for updated artificial intelligence (AI) capabilities. 
News | Wearables
FDA Clears Smaller iRhythm Monitor with AI Arrhythmia Detection

May 25, 2021 — iRhythm Technologies Inc. announced two new U.S. Food and Drug Administration (FDA) 510(k) clearances — ...

Home May 25, 2021
Home
AGENT IDE will evaluate the AGENT DCB as potential therapy for patients with in-stent restenosis, may offer alternative to repeated stenting or radiation therapy
News | Balloon Catheter
Boston Scientific Initiates First Coronary Drug-Coated Balloon Study in the U.S.

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
RAFT-AF study showed type of heart failure may influence treatment strategies for heart rate management vs. arrhythmia control in in patients with heart  heart and atrial fibrillation. #ACC21 #ACC2021
News | Heart Failure
Type of Heart Failure May Influence Optimal Approach for AFib Rhythm Control Versus Rate Control Strategy

May 19, 2021 — Among patients with both heart failure and atrial fibrillation (AFib), treatment strategies focused on ...

Home May 19, 2021
Home
ECMO unit in use to support a severely ill patient at the University of Michigan. ECMO was shown to imporve survival and neuro outcomes in sudden cardiac arrest patients who do not respond to standard therapy.
Feature | Sudden Cardiac Arrest
ECMO Increased Survival in Refractory Out-of-Hospital Cardiac Arrest

May 19, 2021 — A subgroup of patients who experienced an out-of-hospital cardiac arrest (OHCA) that did not respond to ...

Home May 19, 2021
Home
Cardiovascular information systems (CVIS) allow storage of in-office echocardiograms, aids report generation and reading echos for several hospitals. Hitachi’s VidiStar CVIS.
Sponsored Content | Feature | Cardiovascular Information Systems (CVIS)
Use of CVIS for Remote Access of Data and Images

The ability of a cardiologist to work remotely can save lives. By leveraging the advantages of a cloud-based ...

Home May 19, 2021
Home
The WASE-COVID Study used the artificial intelligence automated echocardiogram reading software EchoGo-Core from Ultromics to evaluate ejection fraction and left ventricle longitudinal strain in COVID-19 patients to identify risk markers for mortality. The study also compared human vs. AI variability in assessing the exams. #ACC21 #ACC2021
Feature | Coronavirus (COVID-19)
AI Derived Cardiac Echo Measurements Able to Predict COVID-19 Mortality

May 18, 2021 — Artificial intelligence (AI) derived heart measurements were able to predict COVID-19 (SARS-CoV-2) ...

Home May 18, 2021
Home
The results of the GALACTIC-HF trial shows omecamtiv mecarbil offers benefits to severe heart failure patients. #ACC21 #ACC2021 #GALACTICHF
News | Heart Failure
GALACTIC-HF Shows Omecamtiv Mecarbil Brings Greater Benefits for Severe Heart Failure

May 18, 2021 — The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a ...

Home May 18, 2021
Home
AMERICAN COLLEGE OF CARDIOLOGY (ACC) Late-breaking clinical trial study presentations at ACC.21. @ACC21 @ACC2021
Feature | ACC | Dave Fornell, Editor
ACC 2021 Late Breaking Cardiology Study Results

The latest cardiology practice-changing scientific breakthrough, late-breaking study presentations have been announced ...

Home May 18, 2021
Home
Dapagliflozin did not significantly reduce organ failure or death in high-risk hospitalized COVID-19 patients in the DARE-19 trial results, presented at ACC.21. #ACC #ACC21 #ACC2021
News | Coronavirus (COVID-19)
Dapagliflozin Did Not Significantly Reduce Organ Failure or Death in High-Risk Hospitalized COVID-19 Patients

May 18, 2021 — Dapagliflozin (Farxiga), a sodium-glucose co-transporter 2 (SGLT2) inhibitor, did not significantly ...

Home May 18, 2021
Home
Videos | Robotic Systems
VIDEO: Interventional Stroke Care May be Aided by Robotic Cath Lab Telemedicine

Ehtisham Mahmud, M.D., division chief of cardiovascular medicine, director of interventional cardiology and the cardiac ...

Home May 18, 2021
Home
Videos | Robotic Systems
VIDEO: Robotic PCI Performed Well in Real-world Population in the PRECISION GRX Study

Ehtisham Mahmud, M.D., division chief of cardiovascular medicine, director of interventional cardiology and the cardiac ...

Home May 18, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now